GlassScriptPhysician profile
Whitley A Simpson
NPI 1922745157
$3,202.47
in general payments reported to CMS, 2019-2025
22 companies · $741 in 2025
The $741 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $339 · 2023: $1,243 · 2024: $879 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,669 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,668.59 |
| Education | $194.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $882.24 | 2022-2025 | |
| Janssen Biotech, INC. | $349.23 | 2023-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $308.24 | 2022-2025 | Ilumya, Winlevi, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $192.18 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $166.37 | 2022-2024 | Dupixent |
| Genzyme Corporation | $165.19 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $146.61 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $131.35 | 2023-2025 | Nemluvio, Oracea, Aklief |
| Incyte Corporation | $124.25 | 2022-2024 | Opzelura |
| Pfizer INC. | $119.39 | 2023-2025 | |
| Amgen INC. | $103.43 | 2023-2024 | Otezla |
| Lilly USA, LLC | $93.69 | 2022-2025 | Olumiant, Taltz, Ebglyss |
| Ucb, INC. | $90.47 | 2024 | Bimzelx |
| Mayne Pharma Commercial LLC | $61.34 | 2023 | |
| Biofrontera INC. | $61.25 | 2022-2023 | Ameluz, Xepi, Bf-Rhodoled |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $49.60 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.67 | 2022-2024 | Spevigo |
| Leo Pharma INC. | $45.06 | 2023-2025 | Adbry |
| Mallinckrodt Hospital Products INC. | $19.24 | 2024 | Acthar |
| Arcutis Biotherapeutics, INC. | $16.65 | 2023 | |
| Verrica Pharmaceuticals INC. | $16.58 | 2023 | Ycanth |
| Helsinn Therapeutics (U.S.), INC. | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitley Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.